Casey McPherson on Shaping the Future of Rare Disease Treatments

Casey McPherson, Founder and CEO of AlphaRose Therapeutics (formerly Chrysalis Genetics), has an interesting background for someone developing genetic technologies to help treat rare diseases. As a musician based in Austin, Texas, McPherson was inspired to enter the world of drug development and biotechnology after his daughter was diagnosed with a rare genetic condition. In this Pharmaceutical Executive interview, McPherson talks about his journey toward developing a therapeutic for his daughter, as well as changing the overall landscape of therapeutic research for children with rare or ultra-rare genetic diseases.

Watch the exclusive interview: https://ow.ly/pncO50URgQz

In case you missed it, check out all of our Profiles in Medicine video interviews at https://www.pharmexec.com/profiles-in-medicine